Abstract

ABSTRACTGlioblastoma (GB) is the most aggressive and lethal tumour of the central nervous system (CNS). GB cells grow rapidly and display a network of projections, ultra-long tumour microtubes (TMs), that mediate cell to cell communication. GB-TMs infiltrate throughout the brain, enwrap neurons and facilitate the depletion of the signalling molecule wingless (Wg)/WNT from the neighbouring healthy neurons. GB cells establish a positive feedback loop including Wg signalling upregulation that activates cJun N-terminal kinase (JNK) pathway and matrix metalloproteases (MMPs) production, which in turn promote further TMs infiltration, GB progression and neurodegeneration. Thus, cellular and molecular signals other than primary mutations emerge as central players of GB. Using a Drosophila model of GB, we describe the temporal organisation of the main cellular events that occur in GB, including cell-to-cell interactions, neurodegeneration and TM expansion. We define the progressive activation of JNK pathway signalling in GB mediated by the receptor Grindelwald (Grnd) and activated by the ligand Eiger (Egr)/TNFα produced by surrounding healthy brain tissue. We propose that cellular interactions of GB with the healthy brain tissue precede TM expansion and conclude that non-autonomous signals facilitate GB progression. These results contribute to deciphering the complexity and versatility of these incurable tumours.

Highlights

  • Glioblastoma multiforme (GB) is the most frequent and aggressive primary malignant brain tumour, with an incidence of three per 100,000/year (Gallego, 2015)

  • Combined activation of epidermal growth factor receptor (EGFR) and phosphatidylinositol-3 kinase (PI3K) pathways is required for GB progression The Drosophila GB model reproduces the main features of the disease including the expansion of tumour microtubes (TMs)

  • Only glial cells are marked with RFP, and in the Drosophila brain the unlabelled surrounding cells are mostly neuroblasts and neurons that are marked with the neuron specific antibody anti-horseradish peroxidase (Hrp) in green (Fig. S1A) (Portela et al, 2019)

Read more

Summary

Introduction

Glioblastoma multiforme (GB) is the most frequent and aggressive primary malignant brain tumour, with an incidence of three per 100,000/year (Gallego, 2015). The causes of GB are under debate (McGuire, 2016), 5% of the patients develop GB after a low grade astrocytoma (Alifieris and Trafalis, 2015) and the most frequent mutations include gain of function of the epidermal growth factor receptor (EGFR) (97%) and. The genetic and molecular heterogeneity complicate the diagnosis and treatment of these fatal brain tumours

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call